Johnson & Johnson
Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods

Last updated:

Abstract:

The invention provides a composition containing hyaluronic acid (HA) or a pharmaceutically-acceptable salt thereof preserved with a cationic preservative and related methods. In one embodiment, the pharmaceutically-acceptable salt is sodium hyaluronate. In another embodiment, the cationic preservative includes benzalkonium chloride (BAK).

Status:
Grant
Type:

Utility

Filling date:

12 Nov 2018

Issue date:

17 Mar 2020